$A, $BIO, $CSIQ, $LNG, $CTAS, $DHR, $DVA, $MYGN, $TEVA
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID 2019 trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Friday as follows:
Agilent Technologies Inc. (NYSE:A) was started with a Buy rating and assigned a 77 price target at Needham. The stock has a consensus target price of 79.33.
Bio-Rad Laboratories Inc. (NYSE:BIO) was raised to Overweight from Equal Weight with a 315 price target at Barclays.
Canadian Solar Inc. (NASDAQ:CSIQ) was raised to Buy from Neutral with a 19 price target at Goldman Sachs.
Cheniere Energy Inc. (NYSEARCA:LNG) was started with a Buy rating and assigned a 72 target price at UBS.
Cintas Corp. (NASDAQ:CTAS) was raised to Buy from Neutral at Merrill Lynch.
Danaher Corp. (NYSE:DHR) was started with a Buy rating and assigned a 114 target price at Needham.
DaVita Inc. (NYSE:DVA) was started with a Buy rating and assigned a 60 target price at Deutsche Bank.
Myriad Genetics Inc. (NASDAQ:MYGN) was started with a Strong Buy rating and assigned a 36 target price at Needham.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) was raised to Buy from Underperform at Merrill Lynch.
Have a terrific weekend.
Latest posts by Paul Ebeling (see all)
- The Fed Made a Mistake Hiking Rates in December, and Has Admitted It - March 25, 2019
- Ferrari (NYSE:RACE) Built This 1-Off Supercar for Anonymous Client - March 25, 2019
- Key US Treasury Yields Lowest Since December 2017 - March 25, 2019